000 | 01815 a2200601 4500 | ||
---|---|---|---|
005 | 20250516072743.0 | ||
264 | 0 | _c20130904 | |
008 | 201309s 0 0 eng d | ||
022 | _a1473-1150 | ||
024 | 7 |
_a10.1038/tpj.2011.60 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, L | |
245 | 0 | 0 |
_aGenetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. _h[electronic resource] |
260 |
_bThe pharmacogenomics journal _cApr 2013 |
||
300 |
_a110-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers, Pharmacological _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Transformation, Neoplastic |
650 | 0 | 4 |
_aDNA Methylation _xgenetics |
650 | 0 | 4 | _aEpigenomics |
650 | 0 | 4 |
_aEthnicity _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aHaplotypes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganic Cation Transport Proteins _xgenetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
700 | 1 | _aHong, C | |
700 | 1 | _aChen, E C | |
700 | 1 | _aYee, S W | |
700 | 1 | _aXu, L | |
700 | 1 | _aAlmof, E U | |
700 | 1 | _aWen, C | |
700 | 1 | _aFujii, K | |
700 | 1 | _aJohns, S J | |
700 | 1 | _aStryke, D | |
700 | 1 | _aFerrin, T E | |
700 | 1 | _aSimko, J | |
700 | 1 | _aChen, X | |
700 | 1 | _aCostello, J F | |
700 | 1 | _aGiacomini, K M | |
773 | 0 |
_tThe pharmacogenomics journal _gvol. 13 _gno. 2 _gp. 110-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/tpj.2011.60 _zAvailable from publisher's website |
999 |
_c21448404 _d21448404 |